Form 4 for GPCR Structure Therapeutics Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-19 | 2024-03-15 | GPCR | Lin Xichen | CSO | A - Grant | $0.00 | +85.7K | 85.7K | New | $0 |
| D | 2024-03-19 | 2024-03-15 | GPCR | Lin Xichen | CSO | A - Grant | $0.00 | +213.5K | 213.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-15 | A | A | 85,707 | $0.00 | 85,707 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-03-15 | A | A | 213,486 | $0.00 | 213,486 | D | $35.25 · — to 2034-03-14 | 213,486 Ordinary Shares | (F2) 1/4th of the shares subject to the option shall vest March 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. |